Listen to the HealthAlpha podcast. Host Sushaant Bakhru talks to Pharmagro’s Nick Wigdahl
Here we discuss the effects of tariffs, the rise of Asian CDMOs and the role of Private Equity
Asia’s Growing Strength in CDMOs
PHARMAGRO INSIGHTS
More from Pharmagro
CDMOOctober 1, 2026
Case Study : Choosing the Right Manufacturing Partner for a Phase 3 Biologic
How we navigated compounding process changes, non-comparable proposals, and hidden CDMO risks.
Read Insight
Risk ManagementOctober 1, 2026
Case Study: Technical Due Diligence on a Biologic
In just four weeks we provided a strong analysis of CMC elements, embedded in financial, legal and operational issues.
Read Insight
CDMOJune 2, 2026
P2MT Software Update
We have made our Pharmagro Portfolio ManagementTool P2MT easier to use! In the Evaluation Section we have added templates. Use these to get started quickly on your evaluations.
Read Insight